BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25000820)

  • 1. Solid-phase biological assays for drug discovery.
    Forsberg EM; Sicard C; Brennan JD
    Annu Rev Anal Chem (Palo Alto Calif); 2014; 7():337-59. PubMed ID: 25000820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-phase assays for small molecule screening using sol-gel entrapped proteins.
    Lebert JM; Forsberg EM; Brennan JD
    Biochem Cell Biol; 2008 Apr; 86(2):100-10. PubMed ID: 18443623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives.
    Leifer BS; Doyle SK; Richters A; Evans HL; Koehler AN
    Methods Enzymol; 2018; 610():191-218. PubMed ID: 30390799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: high-throughput affinity-based technologies for small-molecule drug discovery.
    Zhu Z; Cuozzo J
    J Biomol Screen; 2009 Dec; 14(10):1157-64. PubMed ID: 19822881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A guided materials screening approach for developing quantitative sol-gel derived protein microarrays.
    Helka BJ; Brennan JD
    J Vis Exp; 2013 Aug; (78):. PubMed ID: 24022739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment screening using X-ray crystallography.
    Davies TG; Tickle IJ
    Top Curr Chem; 2012; 317():33-59. PubMed ID: 21678136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional protein micropatterning for drug design and discovery.
    You C; Piehler J
    Expert Opin Drug Discov; 2016; 11(1):105-19. PubMed ID: 26624534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and application of PI3K assays for novel drug discovery.
    Yanamandra M; Mitra S; Giri A
    Expert Opin Drug Discov; 2015 Feb; 10(2):171-86. PubMed ID: 25547459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
    Gul S; Hadian K
    Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Development of Protein Chips for High Throughput Screening (HTS) of Chemically Labeling Small Molecular Drugs.
    Feng Y; Wang B; Chu X; Wang Y; Zhu L
    Mini Rev Med Chem; 2016; 16(10):846-50. PubMed ID: 25963567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorous-based small-molecule microarrays for protein, antibody and enzyme screening.
    Song EH; Pohl NL
    Future Med Chem; 2009 Aug; 1(5):889-96. PubMed ID: 21426087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and utilization of activated STAT3 detection assays for screening a library of secreted proteins.
    Fursov N; Gates IV; Panavas T; Giles-Komar J; Powers G
    Assay Drug Dev Technol; 2011 Aug; 9(4):420-9. PubMed ID: 21294636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-Based Ligand Discovery for the ENL YEATS Domain.
    Asiaban JN; Milosevich N; Chen E; Bishop TR; Wang J; Zhang Y; Ackerman CJ; Hampton EN; Young TS; Hull MV; Cravatt BF; Erb MA
    ACS Chem Biol; 2020 Apr; 15(4):895-903. PubMed ID: 32176478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancements in Assay Technologies and Strategies to Enable Drug Discovery.
    Busby SA; Carbonneau S; Concannon J; Dumelin CE; Lee Y; Numao S; Renaud N; Smith TM; Auld DS
    ACS Chem Biol; 2020 Oct; 15(10):2636-2648. PubMed ID: 32880443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Small-Molecule Aggregation with High-Throughput Microplate Biophysical Methods.
    Allen SJ; Dower CM; Liu AX; Lumb KJ
    Curr Protoc Chem Biol; 2020 Mar; 12(1):e78. PubMed ID: 32150343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of new technologies for cellular screening along the drug value chain.
    Möller C; Slack M
    Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revolution of Small Molecule Drug Discovery by Affinity Selection-Mass Spectrometry Technology.
    Motoyaji T
    Chem Pharm Bull (Tokyo); 2020; 68(3):191-193. PubMed ID: 32115525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.